Endocrinology, Diabetes & Metabolism

Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions

By Abul Bashar Mohammad Kamrul-Hasan, Arnav Kalra, Nitin Kapoor, Syed Abbas Raza

ReviewInterventions

The paper

Abul Bashar Mohammad Kamrul-Hasan, Arnav Kalra, Nitin Kapoor, Syed Abbas Raza

Mymensingh Medical College Hospital; Shaukat Khanum Memorial Cancer Hospital and Research Center

Endocrinology, Diabetes & Metabolism, 12 Aug 2026

doi.org/10.1002/edm2.70307 PubMed 42581493

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes